Cargando…
Multi-organ landscape of therapy-resistant melanoma
Metastasis and failure of present-day therapies represent the most common causes of mortality in patients with cutaneous melanoma. To identify the underlying genetic and transcriptomic landscapes, in this study we analyzed multi-organ metastases and tumor-adjacent tissues from 11 rapid autopsies aft...
Autores principales: | Liu, Sixue, Dharanipragada, Prashanthi, Lomeli, Shirley H., Wang, Yan, Zhang, Xiao, Yang, Zhentao, Lim, Raymond J., Dumitras, Camelia, Scumpia, Philip O., Dubinett, Steve M., Moriceau, Gatien, Johnson, Douglas B., Moschos, Stergios J., Lo, Roger S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202813/ https://www.ncbi.nlm.nih.gov/pubmed/37106167 http://dx.doi.org/10.1038/s41591-023-02304-9 |
Ejemplares similares
-
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma
por: Dharanipragada, Prashanthi, et al.
Publicado: (2023) -
Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance
por: Yang, Zhentao, et al.
Publicado: (2022) -
SPRED1 deletion confers resistance to MAPK inhibition in melanoma
por: Ablain, Julien, et al.
Publicado: (2020) -
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma
por: Liu, Sixue, et al.
Publicado: (2021) -
Targeted profiling of human extrachromosomal DNA by CRISPR-CATCH
por: Hung, King L., et al.
Publicado: (2022)